Comparison of Cellular Binding and Uptake of Antisense Phosphodiester, Phosphorothioate, and Mixed Phosphorothioate and Methylphosphonate Oligonucleotides
- 1 January 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense Research and Development
- Vol. 3 (1) , 53-66
- https://doi.org/10.1089/ard.1993.3.53
Abstract
The effects of phosphorothioate (S-oligonucleotide) or terminal phosphorothioate-phosphodiester (S-O-oligonucleotides) or methylphosphonate-phosphodiester (MP-O-oligonucleotides) modifications on mouse spleen cell surface binding, uptake, and degradation were studied using fluorescein (FITC)-conjugated oligonucleotides. S-oligonucleotides had the highest cell binding and uptake, followed by S-O-, O-, and MP-O-oligonucleotides. Competition studies indicated that S-oligonucleotides have an increased affinity for cell membrane oligonucleotide binding sites, because they could completely block O-oligonucleotide binding at a molar ratio of just 0.1. Uptake of all oligonucleotides was higher in B cells than T cells and was increased by stimulation with the B-cell mitogen, lipopolysaccharide. Although our cells had been purified using conventional techniques to eliminate dead cells, there remained about 5% of cells that were dead or dying, as determined by flow cytometry using propidium iodide staining. Of note, oligonucleotide association with dead cells was approximately 50-fold greater than that with living cells. Confocal microscopy confirmed that the oligonucleotides in living cells were intracellular, and indicated little nuclear uptake by 4 h. While extensive degradation of intracellular O-oligonucleotides was apparent by 4 h, there was no detectable degradation of S-, S-O, or MP-O-oligonucleotides.Keywords
This publication has 14 references indexed in Scilit:
- Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.Proceedings of the National Academy of Sciences, 1993
- Cellular Uptake and Subcellular Distribution of Phosphorothioate Oligonucleotides into Cultured CellsAntisense Research and Development, 1992
- Phosphorothioate oligodeoxynucleotides—anti-sense inhibitors of gene expression?Pharmacology & Therapeutics, 1991
- Intracellular distribution of microinjected antisense oligonucleotides.Proceedings of the National Academy of Sciences, 1991
- Effects of phosphorothioate capping on antivense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infectionNucleic Acids Research, 1991
- Antisense oligonucleotides: a new therapeutic principleChemical Reviews, 1990
- Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?Proceedings of the National Academy of Sciences, 1989
- Characterization of oligonucleotide transport into living cells.Proceedings of the National Academy of Sciences, 1989
- Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates.Proceedings of the National Academy of Sciences, 1988
- Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.Proceedings of the National Academy of Sciences, 1986